0.75 USD
▲+0.01+1.90%
盘后 0.71 -5.70%
2026-11-20
市值
$1.68M
市盈率
—
EPS
-18.56
股息率
—
52 周区间
0.70 – 23.94
成交量
23.62K
Beta
2.27
目标价
—
52W 低 0.7052W 高 23.94
价格走势
公司简介
HCW Biologics Inc., a clinical-stage biopharmaceutical company, focuses on discovering and developing novel immunotherapies for chronic, low-grade inflammation, and diseases in the United States. Its lead products include HCW11-018b, a novel, tetra-valent T-Cell engager; HCW11-040, a multifunctional fusion molecule that is a combination of cytokines and pembrolizumab; and HCW9302, injectable and interleukin 2 (IL-2) fusion protein complex, which is in clinical trial in patients with alopecia areata diseases. The company also develops HCW9201, a...